Back to EPRX

GOLDMAN SACHS GROUP INC → EPRX

GOLDMAN SACHS GROUP INC EPRX Position History

Eupraxia Pharmaceuticals Inc. • Healthcare

Quarters held
7
Latest value
$384K
Q2 2026
Peak value
$438K
First seen
Q1 2025

Dollar value over time

Show data table
PeriodPosition value
Q1 2025$113K
Q2 2025$229K
Q3 2025$237K
Q4 2025$438K
Q4 2025$438K
Q1 2026$384K
Q2 2026$384K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$384K58.1K——
Q1 2026$384K53.1K——
Q4 2025$438K58.1K——
Q4 2025$438K58.1K——
Q3 2025$237K40.1K——
Q2 2025$229K39.8K——
Q1 2025$113K34.5K——

Other funds holding EPRX

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B
AAPL

APPLE INC

$23.8B
AAPL

APPLE INC

$23.8B